High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies

Details for Australian Patent Application No. 2006236417 (hide)

Owner Amgen Fremont Inc.

Inventors Foord, Orit; Babcook, John; Rathanaswami, Palaniswami; Kang, Jaspal S.

Agent Shelston IP

Pub. Number AU-B-2006236417

PCT Pub. Number WO2006/113643

Priority 60/673,452 20.04.05 US

Filing date 18 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 3 February 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/113643 Priority application(s): WO2006/113643

3 February 2011 Application Accepted

  Published as AU-B-2006236417

2 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236418-System and method for efficiently tracking and dating content in very large dynamic document spaces

2006236410-Fluidic structures including meandering and wide channels